Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Dec, 2015 | Pages:
1011 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Head And Neck Cancer - Pipeline Review, H2 2015 Summary Global Markets Directs, Head And Neck Cancer - Pipeline Review, H2 2015, provides an overview of the Head And Neck Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Head And Neck Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Head And Neck Cancer and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global therapeutic landscape of Head And Neck Cancer - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Head And Neck Cancer and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Head And Neck Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Head And Neck Cancer pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Head And Neck Cancer - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Head And Neck Cancer pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Table of Contents Introduction 9 Head And Neck Cancer Overview 10 Therapeutics Development 11 Head And Neck Cancer - Therapeutics under Development by Companies 13 Head And Neck Cancer - Therapeutics under Investigation by Universities/Institutes 26 Head And Neck Cancer - Pipeline Products Glance 29 Head And Neck Cancer - Products under Development by Companies 33 Head And Neck Cancer - Products under Investigation by Universities/Institutes 51 Head And Neck Cancer - Companies Involved in Therapeutics Development 53 Head And Neck Cancer - Therapeutics Assessment 203 Drug Profiles 228 Head And Neck Cancer - Recent Pipeline Updates 711 Head And Neck Cancer - Dormant Projects 961 Head And Neck Cancer - Discontinued Products 972 Head And Neck Cancer - Product Development Milestones 975 Appendix 982
List of Tables Number of Products under Development for Head And Neck Cancer, H2 2015 39 Number of Products under Development for Head And Neck Cancer - Comparative Analysis, H2 2015 40 Number of Products under Development by Companies, H2 2015 42 Number of Products under Development by Companies, H2 2015 (Contd..1) 43 Number of Products under Development by Companies, H2 2015 (Contd..2) 44 Number of Products under Development by Companies, H2 2015 (Contd..3) 45 Number of Products under Development by Companies, H2 2015 (Contd..4) 46 Number of Products under Development by Companies, H2 2015 (Contd..5) 47 Number of Products under Development by Companies, H2 2015 (Contd..6) 48 Number of Products under Development by Companies, H2 2015 (Contd..7) 49 Number of Products under Development by Companies, H2 2015 (Contd..8) 50 Number of Products under Development by Companies, H2 2015 (Contd..9) 51 Number of Products under Development by Companies, H2 2015 (Contd..10) 52 Number of Products under Development by Companies, H2 2015 (Contd..11) 53 Number of Products under Investigation by Universities/Institutes, H2 2015 55 Number of Products under Investigation by Universities/Institutes, H2 2015 (Contd..1) 56 Comparative Analysis by Late Stage Development, H2 2015 57 Comparative Analysis by Clinical Stage Development, H2 2015 58 Comparative Analysis by Early Stage Development, H2 2015 59 Comparative Analysis by Unknown Stage Development, H2 2015 60 Products under Development by Companies, H2 2015 61 Products under Development by Companies, H2 2015 (Contd..1) 62 Products under Development by Companies, H2 2015 (Contd..2) 63 Products under Development by Companies, H2 2015 (Contd..3) 64 Products under Development by Companies, H2 2015 (Contd..4) 65 Products under Development by Companies, H2 2015 (Contd..5) 66 Products under Development by Companies, H2 2015 (Contd..6) 67 Products under Development by Companies, H2 2015 (Contd..7) 68 Products under Development by Companies, H2 2015 (Contd..8) 69 Products under Development by Companies, H2 2015 (Contd..9) 70 Products under Development by Companies, H2 2015 (Contd..10) 71 Products under Development by Companies, H2 2015 (Contd..11) 72 Products under Development by Companies, H2 2015 (Contd..12) 73 Products under Development by Companies, H2 2015 (Contd..13) 74 Products under Development by Companies, H2 2015 (Contd..14) 75 Products under Development by Companies, H2 2015 (Contd..15) 76 Products under Development by Companies, H2 2015 (Contd..16) 77 Products under Development by Companies, H2 2015 (Contd..17) 78 Products under Investigation by Universities/Institutes, H2 2015 79 Products under Investigation by Universities/Institutes, H2 2015 (Contd..1) 80 Head And Neck Cancer - Pipeline by 4SC AG, H2 2015 81 Head And Neck Cancer - Pipeline by AB Science SA, H2 2015 82 Head And Neck Cancer - Pipeline by AbbVie Inc., H2 2015 83 Head And Neck Cancer - Pipeline by Acceleron Pharma, Inc., H2 2015 84 Head And Neck Cancer - Pipeline by Advaxis, Inc., H2 2015 85 Head And Neck Cancer - Pipeline by Alchemia Limited, H2 2015 86 Head And Neck Cancer - Pipeline by Altor BioScience Corporation, H2 2015 87 Head And Neck Cancer - Pipeline by Ambrx, Inc., H2 2015 88 Head And Neck Cancer - Pipeline by Amgen Inc., H2 2015 89 Head And Neck Cancer - Pipeline by ANP Technologies, Inc., H2 2015 90 Head And Neck Cancer - Pipeline by arGEN-X BV, H2 2015 91 Head And Neck Cancer - Pipeline by ArQule, Inc., H2 2015 92 Head And Neck Cancer - Pipeline by Ascenta Therapeutics, Inc., H2 2015 93 Head And Neck Cancer - Pipeline by Astellas Pharma Inc., H2 2015 94 Head And Neck Cancer - Pipeline by Astex Pharmaceuticals, Inc., H2 2015 95 Head And Neck Cancer - Pipeline by AstraZeneca Plc, H2 2015 96 Head And Neck Cancer - Pipeline by ATLAB Pharma SAS, H2 2015 97 Head And Neck Cancer - Pipeline by AVEO Pharmaceuticals, Inc., H2 2015 98 Head And Neck Cancer - Pipeline by Bayer AG, H2 2015 99 Head And Neck Cancer - Pipeline by Bexion Pharmaceuticals, LLC., H2 2015 100 Head And Neck Cancer - Pipeline by BIND Therapeutics, Inc., H2 2015 101 Head And Neck Cancer - Pipeline by Bio-Path Holdings, Inc., H2 2015 102 Head And Neck Cancer - Pipeline by BioDiem Ltd, H2 2015 103 Head And Neck Cancer - Pipeline by Bionovis SA, H2 2015 104 Head And Neck Cancer - Pipeline by Biotest AG, H2 2015 105 Head And Neck Cancer - Pipeline by Boehringer Ingelheim GmbH, H2 2015 106 Head And Neck Cancer - Pipeline by Boston Biomedical, Inc., H2 2015 107 Head And Neck Cancer - Pipeline by Bristol-Myers Squibb Company, H2 2015 108 Head And Neck Cancer - Pipeline by CEL-SCI Corporation, H2 2015 109 Head And Neck Cancer - Pipeline by Celgene Corporation, H2 2015 110 Head And Neck Cancer - Pipeline by Cell Medica Limited, H2 2015 111 Head And Neck Cancer - Pipeline by Cellceutix Corporation, H2 2015 112 Head And Neck Cancer - Pipeline by Celldex Therapeutics, Inc., H2 2015 113 Head And Neck Cancer - Pipeline by Celltrion, Inc., H2 2015 114 Head And Neck Cancer - Pipeline by Centrose LLC, H2 2015 115 Head And Neck Cancer - Pipeline by Cristal Therapeutics, H2 2015 116 Head And Neck Cancer - Pipeline by Critical Outcome Technologies Inc., H2 2015 117 Head And Neck Cancer - Pipeline by CTI BioPharma Corp., H2 2015 118 Head And Neck Cancer - Pipeline by CytomX Therapeutics, Inc., H2 2015 119 Head And Neck Cancer - Pipeline by Daiichi Sankyo Company, Limited, H2 2015 120 Head And Neck Cancer - Pipeline by EcoBiotics Limited, H2 2015 121 Head And Neck Cancer - Pipeline by Eisai Co., Ltd., H2 2015 122 Head And Neck Cancer - Pipeline by Eli Lilly and Company, H2 2015 123 Head And Neck Cancer - Pipeline by EntreChem, S.L., H2 2015 124 Head And Neck Cancer - Pipeline by Etubics Corporation, H2 2015 125 Head And Neck Cancer - Pipeline by Eureka Therapeutics, Inc., H2 2015 126 Head And Neck Cancer - Pipeline by F. Hoffmann-La Roche Ltd., H2 2015 127 Head And Neck Cancer - Pipeline by Five Prime Therapeutics, Inc., H2 2015 128 Head And Neck Cancer - Pipeline by G&E Herbal Biotechnology Co., Ltd., H2 2015 129 Head And Neck Cancer - Pipeline by Genelux Corporation, H2 2015 130 Head And Neck Cancer - Pipeline by Genentech, Inc., H2 2015 131 Head And Neck Cancer - Pipeline by Genexine, Inc., H2 2015 132 Head And Neck Cancer - Pipeline by Genmab A/S, H2 2015 133 Head And Neck Cancer - Pipeline by Genticel S.A., H2 2015 134 Head And Neck Cancer - Pipeline by GlaxoSmithKline Plc, H2 2015 135 Head And Neck Cancer - Pipeline by Gliknik, Inc., H2 2015 136 Head And Neck Cancer - Pipeline by Glycotope GmbH, H2 2015 137 Head And Neck Cancer - Pipeline by Green Cross Corporation, H2 2015 138 Head And Neck Cancer - Pipeline by Hanmi Pharmaceuticals, Co. Ltd., H2 2015 139 Head And Neck Cancer - Pipeline by HEC Pharm Co., Ltd., H2 2015 140 Head And Neck Cancer - Pipeline by Horizon Pharma Plc, H2 2015 141 Head And Neck Cancer - Pipeline by Ignyta, Inc., H2 2015 142 Head And Neck Cancer - Pipeline by ImmunoGen, Inc., H2 2015 143 Head And Neck Cancer - Pipeline by Immunomedics, Inc., H2 2015 144 Head And Neck Cancer - Pipeline by Immunovaccine, Inc., H2 2015 145 Head And Neck Cancer - Pipeline by Immunovative Therapies, Ltd., H2 2015 146 Head And Neck Cancer - Pipeline by Incyte Corporation, H2 2015 147 Head And Neck Cancer - Pipeline by Innate Pharma SA, H2 2015 148 Head And Neck Cancer - Pipeline by Inovio Pharmaceuticals, Inc., H2 2015 149 Head And Neck Cancer - Pipeline by InteRNA Technologies B.V., H2 2015 150 Head And Neck Cancer - Pipeline by IRX Therapeutics, Inc., H2 2015 151 Head And Neck Cancer - Pipeline by ISA Pharmaceuticals B.V., H2 2015 152 Head And Neck Cancer - Pipeline by ISU ABXIS Co.,Ltd., H2 2015 153 Head And Neck Cancer - Pipeline by Jiangsu Kanion Pharmaceutical Co., Ltd., H2 2015 154 Head And Neck Cancer - Pipeline by Johnson & Johnson, H2 2015 155 Head And Neck Cancer - Pipeline by Karyopharm Therapeutics, Inc., H2 2015 156 Head And Neck Cancer - Pipeline by Kite Pharma, Inc., H2 2015 157 Head And Neck Cancer - Pipeline by Kolltan Pharmaceuticals, Inc., H2 2015 158 Head And Neck Cancer - Pipeline by Laboratoires Pierre Fabre SA, H2 2015 159 Head And Neck Cancer - Pipeline by Loxo Oncology, Inc., H2 2015 160 Head And Neck Cancer - Pipeline by Lytix Biopharma AS, H2 2015 161 Head And Neck Cancer - Pipeline by Mabion SA, H2 2015 162 Head And Neck Cancer - Pipeline by Mabtech Limited, H2 2015 163 Head And Neck Cancer - Pipeline by MacroGenics, Inc., H2 2015 164 Head And Neck Cancer - Pipeline by Marsala Biotech Inc., H2 2015 165 Head And Neck Cancer - Pipeline by Meabco A/S, H2 2015 166 Head And Neck Cancer - Pipeline by MedImmune, LLC, H2 2015 167 Head And Neck Cancer - Pipeline by Merck & Co., Inc., H2 2015 168 Head And Neck Cancer - Pipeline by Merck KGaA, H2 2015 169 Head And Neck Cancer - Pipeline by Merrimack Pharmaceuticals, Inc., H2 2015 170 Head And Neck Cancer - Pipeline by Mirati Therapeutics Inc., H2 2015 171 Head And Neck Cancer - Pipeline by Molplex Ltd., H2 2015 172 Head And Neck Cancer - Pipeline by Multimmune GmbH, H2 2015 173 Head And Neck Cancer - Pipeline by NanoCarrier Co., Ltd., H2 2015 174 Head And Neck Cancer - Pipeline by Natco Pharma Limited, H2 2015 175 Head And Neck Cancer - Pipeline by Northwest Biotherapeutics, Inc., H2 2015 176 Head And Neck Cancer - Pipeline by Novartis AG, H2 2015 177 Head And Neck Cancer - Pipeline by Omnitura Therapeutics Inc., H2 2015 178 Head And Neck Cancer - Pipeline by Oncobiologics, Inc., H2 2015 179 Head And Neck Cancer - Pipeline by Oncolys BioPharma Inc., H2 2015 180 Head And Neck Cancer - Pipeline by Oncolytics Biotech Inc., H2 2015 181 Head And Neck Cancer - Pipeline by Onconova Therapeutics, Inc., H2 2015 182 Head And Neck Cancer - Pipeline by OncoSec Medical Inc., H2 2015 183 Head And Neck Cancer - Pipeline by Ono Pharmaceutical Co., Ltd., H2 2015 184 Head And Neck Cancer - Pipeline by Orbis Biosciences, Inc., H2 2015 185 Head And Neck Cancer - Pipeline by Oryx GmbH & Co. KG, H2 2015 186 Head And Neck Cancer - Pipeline by Otsuka Holdings Co., Ltd., H2 2015 187 Head And Neck Cancer - Pipeline by OXiGENE, Inc., H2 2015 188 Head And Neck Cancer - Pipeline by Panacea Biotec Limited, H2 2015 189 Head And Neck Cancer - Pipeline by PCI Biotech AS, H2 2015 190 Head And Neck Cancer - Pipeline by Pfizer Inc., H2 2015 191 Head And Neck Cancer - Pipeline by Pharma Mar, S.A., H2 2015 192 Head And Neck Cancer - Pipeline by Pharmacyclics, Inc., H2 2015 193 Head And Neck Cancer - Pipeline by Pique Therapeutics, H2 2015 194 Head And Neck Cancer - Pipeline by Plexxikon Inc., H2 2015 195 Head And Neck Cancer - Pipeline by PNP Therapeutics, Inc., H2 2015 196 Head And Neck Cancer - Pipeline by Profectus BioSciences, Inc., H2 2015 197 Head And Neck Cancer - Pipeline by Redx Pharma Plc, H2 2015 198 Head And Neck Cancer - Pipeline by Sanofi, H2 2015 199 Head And Neck Cancer - Pipeline by Sapvax, H2 2015 200 Head And Neck Cancer - Pipeline by Sareum Holdings Plc, H2 2015 201 Head And Neck Cancer - Pipeline by Selecta Biosciences, Inc., H2 2015 202 Head And Neck Cancer - Pipeline by Serina Therapeutics, Inc., H2 2015 203 Head And Neck Cancer - Pipeline by Shanghai Henlius Biotech Co., Ltd., H2 2015 204 Head And Neck Cancer - Pipeline by Shenzen SiBiono GeneTech Co., Ltd, H2 2015 205 Head And Neck Cancer - Pipeline by Shionogi & Co., Ltd., H2 2015 206 Head And Neck Cancer - Pipeline by Silence Therapeutics Plc, H2 2015 207 Head And Neck Cancer - Pipeline by Sillajen Biotherapeutics, H2 2015 208 Head And Neck Cancer - Pipeline by Sinil Pharmaceutical Co., Ltd, H2 2015 209 Head And Neck Cancer - Pipeline by Sorrento Therapeutics, Inc., H2 2015 210 Head And Neck Cancer - Pipeline by SuviCa Inc., H2 2015 211 Head And Neck Cancer - Pipeline by Symphogen A/S, H2 2015 212 Head And Neck Cancer - Pipeline by Synta Pharmaceuticals Corp., H2 2015 213 Head And Neck Cancer - Pipeline by Taiwan Liposome Company, Ltd., H2 2015 214 Head And Neck Cancer - Pipeline by Takara Bio Inc., H2 2015 215 Head And Neck Cancer - Pipeline by Takis S.r.l., H2 2015 216 Head And Neck Cancer - Pipeline by Teva Pharmaceutical Industries Limited, H2 2015 217 Head And Neck Cancer - Pipeline by Theravectys SA, H2 2015 218 Head And Neck Cancer - Pipeline by Threshold Pharmaceuticals, Inc., H2 2015 219 Head And Neck Cancer - Pipeline by Tolero Pharmaceuticals, Inc., H2 2015 220 Head And Neck Cancer - Pipeline by Vaccibody AS, H2 2015 221 Head And Neck Cancer - Pipeline by VasGene Therapeutics, Inc., H2 2015 222 Head And Neck Cancer - Pipeline by VentiRx Pharmaceuticals, Inc., H2 2015 223 Head And Neck Cancer - Pipeline by Virttu Biologics Limited, H2 2015 224 Head And Neck Cancer - Pipeline by Viventia Bio Inc., H2 2015 225 Head And Neck Cancer - Pipeline by VLPbio, H2 2015 226 Head And Neck Cancer - Pipeline by VM Discovery, Inc., H2 2015 227 Head And Neck Cancer - Pipeline by Zhejiang BetaPharma Co., Ltd., H2 2015 228 Head And Neck Cancer - Pipeline by Zymeworks Inc., H2 2015 229 Head And Neck Cancer - Pipeline by Zyngenia, Inc., H2 2015 230 Assessment by Monotherapy Products, H2 2015 231 Assessment by Combination Products, H2 2015 232 Number of Products by Stage and Target, H2 2015 234 Number of Products by Stage and Mechanism of Action, H2 2015 245 Number of Products by Stage and Route of Administration, H2 2015 253 Number of Products by Stage and Molecule Type, H2 2015 255 Head And Neck Cancer Therapeutics - Recent Pipeline Updates, H2 2015 739 Head And Neck Cancer - Dormant Projects, H2 2015 989 Head And Neck Cancer - Dormant Projects (Contd..1), H2 2015 990 Head And Neck Cancer - Dormant Projects (Contd..2), H2 2015 991 Head And Neck Cancer - Dormant Projects (Contd..3), H2 2015 992 Head And Neck Cancer - Dormant Projects (Contd..4), H2 2015 993 Head And Neck Cancer - Dormant Projects (Contd..5), H2 2015 994 Head And Neck Cancer - Dormant Projects (Contd..6), H2 2015 995 Head And Neck Cancer - Dormant Projects (Contd..7), H2 2015 996 Head And Neck Cancer - Dormant Projects (Contd..8), H2 2015 997 Head And Neck Cancer - Dormant Projects (Contd..9), H2 2015 998 Head And Neck Cancer - Dormant Projects (Contd..10), H2 2015 999 Head And Neck Cancer - Discontinued Products, H2 2015 1000 Head And Neck Cancer - Discontinued Products (Contd..1), H2 2015 1001 Head And Neck Cancer - Discontinued Products (Contd..2), H2 2015 1002
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
